Slate Path Capital LP Quant / Systematic

Location: New York, NY

CIK: 0001559706 · Show all filings

Period: Q2 2016 (← Previous) (Next →)

Filing Date: Aug 15, 2016

Total Value: $1.279B (100.0% shares, 0.0% debt)

Holdings (13)

GDX VANECK VECTORS ETF TR 19.5%
Value $249M Shares 8,990,000 Share Price $27.71 Est. Cost/Share $27.71 Unrealized @ Report Date —
PYPL PAYPAL HLDGS INC 16.8%
Value $215M Shares 5,880,000 Share Price $36.51 * Est. Cost/Share $35.61 Unrealized @ Report Date +7.1%
CHTR CHARTER COMMUNICATIONS INC N 13.4%
Value $171M Shares 750,000 Share Price $228.64 * Est. Cost/Share $214.89 Unrealized @ Report Date 0.0%
TRIP TRIPADVISOR INC 9.4%
Value $121M Shares 1,875,000 Share Price $64.30 * Est. Cost/Share $65.57 Unrealized @ Report Date -12.1%
— SYMANTEC CORP 8.8%
Value $113M Shares 5,505,000 Share Price $20.54 Est. Cost/Share $20.54 Unrealized @ Report Date —
PODD INSULET CORP 6.4%
Value $82.25M Shares 2,720,000 Share Price $30.24 * Est. Cost/Share $32.83 Unrealized @ Report Date -5.2%
TECK TECK RESOURCES LTD 6.3%
Value $80.53M Shares 6,115,000 Share Price $13.17 * Est. Cost/Share $10.33 Unrealized @ Report Date 0.0%
— TESORO CORP 5.8%
Value $74.55M Shares 995,000 Share Price $74.92 Est. Cost/Share $74.71 Unrealized @ Report Date —
— ALCOA INC 5.1%
Value $65.26M Shares 7,040,000 Share Price $9.27 Est. Cost/Share $9.27 Unrealized @ Report Date —
ALNY ALNYLAM PHARMACEUTICALS INC 4.9%
Value $62.98M Shares 1,135,000 Share Price $55.49 * Est. Cost/Share $59.29 Unrealized @ Report Date +6.3%
— OPHTHOTECH CORP 1.7%
Value $21.94M Shares 430,000 Share Price $51.03 Est. Cost/Share $42.27 Unrealized @ Report Date —
— UNITED STATES STL CORP NEW 1.0%
Value $12.64M Shares 750,000 Share Price $16.86 Est. Cost/Share $16.86 Unrealized @ Report Date —
— ATARA BIOTHERAPEUTICS INC 0.7%
Value $9.454M Shares 420,000 Share Price $22.51 Est. Cost/Share $22.51 Unrealized @ Report Date —